This inventor holds 1 USPTO granted patent. Top assignee: Syntex (u.s.a.) Inc.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Innovations in Ophthalmic Formulations by Roger F Cherng-Chyi
Introduction
Roger F Cherng-Chyi is an accomplished inventor based in Los Altos, California. He has made significant contributions to the field of ophthalmology through his innovative patent work. His expertise lies in developing formulations that address various eye-related conditions.
Latest Patents
Roger F Cherng-Chyi holds a patent for "Ophthalmic NSAID formulations containing a quaternary ammonium." This patent describes stable, clear, and antimicrobially effective ophthalmic formulations. These formulations include an ophthalmologically effective amount of a drug, particularly a --COOH group-containing drug or a non-steroidal anti-inflammatory drug (NSAID), along with a preservative system formed of a quaternary ammonium preservative and a nonionic surfactant, all in an aqueous vehicle. The formulations are designed to treat diseases associated with inflammatory processes, including glaucoma, cystoid macular edema, uveitis, diabetic retinopathy, and conjunctivitis, as well as trauma caused by eye surgery or injury. He has 1 patent to his name.
Career Highlights
Roger has worked with Syntex (U.S.A.) Inc., where he has been able to apply his innovative ideas in the development of ophthalmic products. His work has contributed to advancements in the treatment of various eye diseases, showcasing his commitment to improving patient care.
Collaborations
Roger has collaborated with Deborah M Lidgate, further enhancing the research and development efforts in their field. Their partnership has led to significant advancements in ophthalmic formulations.
Conclusion
Roger F Cherng-Chyi's contributions to ophthalmic formulations demonstrate his dedication to innovation in the medical field. His work continues to impact the treatment of eye diseases, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile